Cargando…

Could KL-6 levels in COVID-19 help to predict lung disease?

BACKGROUND: Coronavirus disease COVID-19 has become a public health emergency of international concern. Together with the quest for an effective treatment, the question of the post-infectious evolution of affected patients in healing process remains uncertain. Krebs von den Lungen 6 (KL-6) is a high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frix, AN, Schoneveld, L., Ladang, A., Henket, M., Duysinx, B., Vaillant, F., Misset, B., Moutschen, M., Louis, R., Cavalier, E., Guiot, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683867/ https://www.ncbi.nlm.nih.gov/pubmed/33234132 http://dx.doi.org/10.1186/s12931-020-01560-4

Ejemplares similares

YKL-40 as a new promising prognostic marker of severity in COVID infection
por: Schoneveld, Lauranne, et al.
Publicado: (2021)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic
por: Guiot, J., et al.
Publicado: (2020)

Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection
por: Calmes, Doriane, et al.
Publicado: (2021)

KL-6 levels in COVID-19
por: Scarpati, G, et al.
Publicado: (2020)

White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer
por: Sibille, A., et al.
Publicado: (2021)

Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity
por: Guiot, Julien, et al.
Publicado: (2022)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022)

Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients
por: Bocci, Silvia, et al.
Publicado: (2023)

Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia
por: Kim, Si-Ho, et al.
Publicado: (2022)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

KL-6 in acute lung injury: will it leave its mark?
por: Shyamsundar, Murali, et al.
Publicado: (2008)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
por: Denis, Anna, et al.
Publicado: (2022)

Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
por: Scotto, Riccardo, et al.
Publicado: (2021)

A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome
por: Parzibut, Gilles, et al.
Publicado: (2021)

Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD
por: Corhay, Jean Louis, et al.
Publicado: (2014)

Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
por: De Niet, Sophie, et al.
Publicado: (2022)

KL-6 in ARDS and COVID-19 Patients
por: Piazza, Ornella, et al.
Publicado: (2022)

Ageing and long-term smoking affects KL-6 levels in the lung, induced sputum and plasma
por: Ishikawa, Nobuhisa, et al.
Publicado: (2011)

Expression of S100A9 and KL-6 in common interstitial lung diseases
por: Lin, Li, et al.
Publicado: (2022)

Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease
por: Jehn, Lutz B., et al.
Publicado: (2023)

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
por: Park, Hwa Kyung, et al.
Publicado: (2023)

Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
por: Guiot, J., et al.
Publicado: (2017)

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Cousin, François, et al.
Publicado: (2023)

Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
por: Lee, Jeong Seok, et al.
Publicado: (2019)

Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation
por: Berastegui, Cristina, et al.
Publicado: (2020)

Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19
por: Guiot, Julien, et al.
Publicado: (2020)

Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
por: Radermecker, Coraline, et al.
Publicado: (2020)

Prognostic role of blood KL-6 in rheumatoid arthritis–associated interstitial lung disease
por: Kim, Ho Cheol, et al.
Publicado: (2020)

Serial KL-6 measurements in COVID-19 patients
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Self-medication among medical students: What strategies could help?
por: Walsh, Kieran
Publicado: (2014)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Draft Genome Sequences of Pseudomonas moraviensis UCD-KL30, Vibrio ostreicida UCD-KL16, Colwellia sp. Strain UCD-KL20, Shewanella sp. Strain UCD-KL12, and Shewanella sp. Strain UCD-KL21, Isolated from Seagrass
por: Lujan, Karley M., et al.
Publicado: (2017)

Keynote Lectures (KL)
Publicado: (2017)

Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients
por: Determann, Rogier M, et al.
Publicado: (2010)

Blood KL-6 predicts prognosis in primary Sjögren’s syndrome-associated interstitial lung disease
por: Kim, Yun Jae, et al.
Publicado: (2022)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
por: Mostafa, Amira Ismail, et al.
Publicado: (2021)

Impact of Ninjin’yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice
por: Amitani, Haruka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dp23u62sokp2qeak7gecramco2